AbbVie company Allergan Aesthetics announced the celebration of a milestone moment for BOTOX® Cosmetic (onabotulinumtoxinA). April 15, 2022, marks 20 years since the U.S. Food and Drug Administration first approved the product to temporarily improve the look of moderate to severe glabellar lines, located between your eyebrows.

The American Society for Aesthetic Plastic Surgery (ASAPS) reports that Americans spent more than $15 billion during 2016 on combined surgical and nonsurgical aesthetic procedures for the first time ever, accounting for an 11% increase over 2015 alone. Surgical procedures account for 56% and nonsurgical procedures account for 44% of the total.